GAMMA Investing’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
MNBTD
YIH
PFSRSONJ
DT
IA
SOADOR
FFA
VCM
GAMMA Investing's ANGO Position: Q2 2026 in Review
GAMMA Investing increased its AngioDynamics (ANGO) stake by 17% in Q2 2026, buying an estimated $3.7K and bringing the position to 2,184 shares worth $28.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2653.
GAMMA Investing first reported a position in ANGO in Q4 2023 and has held it in 11 quarters since. 16 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.
- GAMMA Investing held 2,184 shares of AngioDynamics worth $28.4K as of Q2 2026.
- GAMMA Investing bought 325 AngioDynamics shares in Q2 2026, an estimated $3.7K.
- AngioDynamics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2653 holding.
- GAMMA Investing first reported a position in AngioDynamics in Q4 2023 and has held it in 11 quarters since.
- 16 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.
Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.